Research Overview
Director, Cornell HIV Clinical Trials Unit
Dr. Gulick is Director of the Cornell HIV Clinical Trials Unit (CCTU). He serves as Principal Investigator of the Cornell Clinical Trials Unit and the Chairman of the Optimization of Antiretroviral Therapy Committee of the National Institutes of Health-funded AIDS Clinical Trials Group (ACTG). His current research focuses on clinical trials of antiretroviral therapy for the treatment of HIV infection. Current projects include studies of new antiretroviral agents (e.g., vicriviroc, bevirimat) and studies evaluating strategies for both antiretroviral treatment-naive and treatment-experienced HIV-infected patients.
